Intravitreal rituximab for the treatment of intraocular relapse of non-Hodgkin’s lymphoma

Intravitreal rituximab for the treatment of intraocular relapse of non-Hodgkin’s lymphoma

Saved in:

Bibliographic Details
Main Authors:	Eva Fernández Cañabate, Sonia Fernández-Cañabate
Format:	Article
Language:	English
Published:	Elsevier 2018-01-01
Series:	Farmacia Hospitalaria
Online Access:	http://www.aulamedica.es/fh/pdf/10830.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Use of Rituximab in Autoimmune Hemolytic Anemia Associated with Non-Hodgkin Lymphomas
by: Claudio Fozza, et al.
Published: (2011-01-01)

Peripheral T Cell Non-Hodgkin’s Lymphoma following Treatment of Hodgkin’s Lymphoma
by: Sun Hee Chang, et al.
Published: (2015-01-01)

Outcome of Very Late Relapse in Patients with Hodgkin's Lymphomas
by: Francesco Gaudio, et al.
Published: (2011-01-01)

The Role of Allogeneic Stem Cell Transplantation in Relapsed/Refractory Hodgkin's Lymphoma Patients
by: Evgeny Klyuchnikov, et al.
Published: (2011-01-01)

NonHodgkin's Lymphoma with Peritoneal Localization
by: E. Curakova, et al.
Published: (2014-01-01)

The monitoring of B lymphocytes in non-lymphoma patients following rituximab treatment
by: Linjie Dong, et al.
Published: (2024-11-01)

CURRENT ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION FOR RELAPSED AND REFRACTORY HODGKIN LYMPHOMA
by: Luca Castagna, et al.
Published: (2015-02-01)

Post-therapy B regulatory cells might early predict relapse in Hodgkin lymphoma
by: Valentina Giudice, et al.
Published: (2022-04-01)

The Efficacy and Safety of Lenalidomide plus Rituximab in an Orbital Relapse of Diffuse Large B-Cell Lymphoma
by: R. Palmieri, et al.
Published: (2019-01-01)

Fifteen-year follow-up of relapsed indolent non-Hodgkin lymphoma patients vaccinated with tumor-loaded dendritic cells
by: Giovanni Fucà, et al.
Published: (2021-06-01)

Hodgkin Lymphoma Mimicking Lung Carcinoma
by: Julio Ricardo Torres Bermúdez, et al.
Published: (2024-10-01)

Monoclonal Antibodies for Non-Hodgkin's Lymphoma: State of the Art and Perspectives
by: Giulia Motta, et al.
Published: (2010-01-01)

Primary T-Cell Non-Hodgkin Lymphoma of the Vagina
by: J. L. Herraiz, et al.
Published: (2015-01-01)

Implementation of an anti-flu vaccination campaign in a hospital pharmacy service
by: Eva Fernández-Cañabate, et al.
Published: (2020-03-01)

Epstein–Barr Virus Driven Hodgkin’s Lymphoma after a Short Course of Daratumumab Treatment for Relapsed Multiple Myeloma
by: Moeen Mohammadi-Oroujeh, et al.
Published: (2023-01-01)

Biologic therapies committee. What does it provide?
by: Virginia Martínez-Santana, et al.
Published: (2021-01-01)

Bone Marrow Infiltration Is a Distinctive Risk Factor for Rituximab Infusion-Related Reactions in CD20-Positive B-Cell Non-Hodgkin Lymphoma
by: Shinya Ohata, et al.
Published: (2022-01-01)

Role of Radiotherapy in Modern Treatment of Hodgkin's Lymphoma
by: Kheng-Wei Yeoh, et al.
Published: (2011-01-01)

EBV IN HODGKIN LYMPHOMA
by: Stefan Hohaus, et al.
Published: (2009-11-01)

PATHOBIOLOGY OF HODGKIN LYMPHOMA
by: Claudio Agostinelli, et al.
Published: (2014-06-01)

EBV IN HODGKIN LYMPHOMA
by: Giuseppina Massini, et al.
Published: (2009-11-01)

The Diagnostic Characteristics of Pediatric Non-Hodgkin Lymphoma Patients
by: Betül Sevinir, et al.
Published: (2009-12-01)

Anaplastic, T-Cell, Non-Hodgkin's Lymphoma Presenting with Haematuria
by: C. Blick, et al.
Published: (2008-01-01)

Digital Gangrene: An Unusual Manifestation of Non-Hodgkin Lymphoma
by: Muhammad Shoaib Momen Majumder, et al.
Published: (2022-01-01)

Use of rituximab in mature, high-grade and advanced-stage pediatric B-lineage non-Hodgkin lymphomas: a systematic review, meta-analysis and the Brazilian reality
by: Alejandra Adriana Cardoso de Castro, et al.
Published: (2025-01-01)

Therapeutic Activity of Lenalidomide in Mantle Cell Lymphoma and Indolent Non-Hodgkin’s Lymphomas
by: Marco Gunnellini, et al.
Published: (2012-01-01)

Obstructive Jaundice as an Initial Manifestation of Non-Hodgkin Lymphoma: Treatment Dilemma and High Mortality
by: Dhara Chaudhari, et al.
Published: (2013-01-01)

TREATMENT OF EARLY STAGES HODGKIN LYMPHOMA DURING PREGNANCY
by: Agustin Avilès, et al.
Published: (2018-01-01)

Brentuximab Vedotin Treatment for Primary Refractory Hodgkin Lymphoma
by: Hung-Bo Wu, et al.
Published: (2013-01-01)

Real life clinical outcomes of relapsed/refractory diffuse large B cell lymphoma in the rituximab era: The STRIDER study
by: Irene Dogliotti, et al.
Published: (2024-07-01)

Gene expression profiling in B-cell non-Hodgkin lymphomas
by: Renas N. Saleem, et al.
Published: (2024-12-01)

THERAPY-RELATED MYELOID NEOPLASM IN NON-HODGKIN LYMPHOMA SURVIVORS
by: Raffaella Marcheselli, et al.
Published: (2011-01-01)

THERAPY-RELATED MYELOID NEOPLASM IN NON-HODGKIN LYMPHOMA SURVIVORS
by: Alessia Bari, et al.
Published: (2011-12-01)

Five Cases of Non-Hodgkin B-Cell Lymphoma of the Ovary
by: Taylan Senol, et al.
Published: (2014-01-01)

Non-Hodgkin's lymphoma in the practice of the family doctor (clinical observation).
by: I. V. Vasylevska
Published: (2018-05-01)

PROGNOSTIC FACTORS IN HODGKIN LYMPHOMA
by: Annarosa Cuccaro, et al.
Published: (2014-07-01)

Intralesional rituximab in ocular adnexal lymphoma
by: P. Crespo Robledo, et al.
Published: (2014-07-01)

Against the odds: Managing pediatric relapsed/refractory Hodgkin lymphoma with autologous stem cell transplant in resource-limited settings
by: Sanjana Sarangarajan, et al.
Published: (2024-01-01)

Polatuzumab vedotin combined with bendamustine and rituximab for relapsed/refractory diffuse large B-cell lymphoma: A systematic review protocol.
by: Mohammadreza Eslami, et al.
Published: (2024-01-01)

A + AVD for Treatment of Hodgkin Lymphoma Variant of Richter’s Transformation
by: Benjamin Heyman, et al.
Published: (2024-01-01)